USE OF ARSENTIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. ARSENIC CAUSES BOTH APOPTOSIS AND PARTIAL DIFFERENTIATION OF NB4 AND FRESH APL CELLS IN-VITRO AND IN-VIVO

CHEN Z CHEN GO SHI XG TANG W ZHU J XIONG SM NI IH GAZIN C WAXMAN S WANG ZY CHEN SJ

Z. Chen et al., USE OF ARSENTIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. ARSENIC CAUSES BOTH APOPTOSIS AND PARTIAL DIFFERENTIATION OF NB4 AND FRESH APL CELLS IN-VITRO AND IN-VIVO, Blood, 88(10), 1996, pp. 864-864

NO

Hematology

Blood → ACNP

00064971

88

10

1996

1

1

864 - 864

ISI

0006-4971(1996)88:10<864:UOAT(I>2.0.ZU;2-Q